Blog Band - Page 299 of 312

In a recent interview with PharmaShots, Dr. Lotus Mallbris, the Vice President of Immunology Development at Eli Lilly shares her insights and highlights on Baricitinib.Shots:If approved, Baricitinib could be the first JAK inhibitor…

Oct 2020

THOUGHTSPOT

Digital Healthcare in India – Current Trends & Future

Digital healthcare means using communications and information technologies in medicine to diagnose, predict, treat, and monitor diseases. It is also widely used for prognosis, rehabilitation, behavioral health, and public health.…

Oct 2020

INSIGHTS+

Insights+ Key Biosimilars Events of September 2020

Biosimilars are developed to be highly similar versions of approved biologics in terms of safety, purity, and potency. Biosimilars are expected to be a cost-effective alternative to the high-priced branded…

Sep 2020

INSIGHTS+

Insights+: COVID-19 Healthcare News Monthly Updates – September 2020

Our planet is facing a major pandemic outbreak due to COVID-19 and health agencies are taking every measure to stop itLife sciences companies are putting all of their efforts…

Sep 2020

THOUGHTSPOT

COVID-19 – Where Does The Pharmaceutical Industry Go From Here?

With the race to develop an effective vaccine becoming intense, how has the coronavirus pandemic changed the pharmaceutical industry, and what can we expect in the long- and short-term? Let's…

Sep 2020

TOP 20

Top 20 Oncology Companies by Total Products of 2019

To remain successful in the oncology market- change is now a key to adapt to this altering market dynamics. A recent development in science and technology platforms are likely to…

Sep 2020

VIEWPOINTS

PharmaShots Interview: Genentech’s Dr. Neil Collinson Shares Insights on Xofluza

In a recent interview with PharmaShots, Dr. Neil Collinson, the Senior Principal Clinical Development Scientist at Genentech / Roche shares his insights and highlights on Xofluza.Shots:The P-III BLOCKSTONE…

Sep 2020

INSIGHTS+

Insights+: The US FDA New Drug Approvals in August 2020

The US FDA has approved multiple NDAs and BLAs in Aug 2020, leading to treatments for patients and advances in the health care industry. The Center for Drug Evaluation and…

Sep 2020

THOUGHTSPOT

COVID-19 Treatment in India and Abroad

In late 2019, a mysterious virus causing infection consisting of dry cough, fever tiredness, and last pneumonia first appeared in Wuhan, China. The world health organization (WHO) named the disease…

Sep 2020

VIEWPOINTS

PharmaShots Interview: Genentech’s Ted Omachi Shares Insights on Xolair (omalizumab) PFS

The US FDA has accepted the sBLA for a new self-administration option for Xolair (omalizumab) across all approved US indications.In an interview with PharmaShots, Ted Omachi the Global Development…

PharmaShots Interview: Eli Lilly’s Dr. Lotus Mallbris Shares Insights on Baricitinib

Digital Healthcare in India – Current Trends & Future

Insights+ Key Biosimilars Events of September 2020

Insights+: COVID-19 Healthcare News Monthly Updates – September 2020

COVID-19 – Where Does The Pharmaceutical Industry Go From Here?

Top 20 Oncology Companies by Total Products of 2019

PharmaShots Interview: Genentech’s Dr. Neil Collinson Shares Insights on Xofluza

Insights+: The US FDA New Drug Approvals in August 2020

COVID-19 Treatment in India and Abroad

PharmaShots Interview: Genentech’s Ted Omachi Shares Insights on Xolair (omalizumab) PFS

Contact US

OUR INFORMATION

FOLLOW US